164 related articles for article (PubMed ID: 35457669)
1. Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal Cancer in a Low-Burden Region of Southern Europe.
Rubió-Casadevall J; Ciurana E; Puigdemont M; Sanvisens A; Marruecos J; Miró J; Urban A; Palhua RL; Martín-Romero F; Ortiz-Duran MR; Marcos-Gragera R
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457669
[No Abstract] [Full Text] [Related]
2. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe.
Mena M; Frias-Gomez J; Taberna M; Quirós B; Marquez S; Clavero O; Baena A; Lloveras B; Alejo M; León X; García J; Mesía R; Bermejo O; Bonfill T; Aguila A; Guix M; Hijano R; Pavón MA; Torres M; Tous S; Clèries R; Alemany L
Sci Rep; 2020 Aug; 10(1):13219. PubMed ID: 32764593
[TBL] [Abstract][Full Text] [Related]
4. Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common.
Wang CP; Chen TC; Hsu WL; Hsiao JR; Chen PR; Chen MK; Hua CH; Tsai MH; Ko JY; Lou PJ; Chiang CJ; Wu CT; Chang YL
BMC Cancer; 2022 Mar; 22(1):296. PubMed ID: 35313837
[TBL] [Abstract][Full Text] [Related]
5. Different protein expression associated with chemotherapy response in oropharyngeal cancer according to HPV status.
Kim MJ; Ki MS; Kim K; Shim HJ; Hwang JE; Bae WK; Chung IJ; Lee DH; Lee JK; Yoon TM; Lim SC; Chung WK; Jeong JU; Lim HS; Choi YD; Cho SH
BMC Cancer; 2014 Nov; 14():824. PubMed ID: 25380690
[TBL] [Abstract][Full Text] [Related]
6. The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil.
Menezes FDS; Latorre MDRDO; Conceição GMS; Curado MP; Antunes JLF; Toporcov TN
PLoS One; 2020; 15(5):e0232871. PubMed ID: 32407339
[TBL] [Abstract][Full Text] [Related]
7. Global burden of oropharyngeal cancer attributable to human papillomavirus by anatomical subsite and geographic region.
Lu Y; Xie Z; Luo G; Yan H; Qian HZ; Fu L; Wang B; Huang R; Cao F; Lin H; You R; Tan L; Yu T; Chen M; Li C; Liu X; Lei W; Zou H
Cancer Epidemiol; 2022 Jun; 78():102140. PubMed ID: 35303618
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and Patient Distribution of Oral Cavity and Oropharyngeal SCC in Canada.
Ghazawi FM; Lu J; Savin E; Zubarev A; Chauvin P; Sasseville D; Zeitouni A; Litvinov IV
J Cutan Med Surg; 2020; 24(4):340-349. PubMed ID: 32238063
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population.
Evans M; Newcombe R; Fiander A; Powell J; Rolles M; Thavaraj S; Robinson M; Powell N
BMC Cancer; 2013 May; 13():220. PubMed ID: 23634887
[TBL] [Abstract][Full Text] [Related]
11. A clinical analysis of oropharyngeal squamous cell carcinoma: a single-institution's experience.
Jiromaru R; Yasumatsu R; Yamamoto H; Kuga R; Hongo T; Nakano T; Manako T; Hashimoto K; Wakasaki T; Matsuo M; Nakagawa T
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3717-3725. PubMed ID: 34978590
[TBL] [Abstract][Full Text] [Related]
12. Double positivity for HPV-DNA/p16
Mena M; Taberna M; Tous S; Marquez S; Clavero O; Quiros B; Lloveras B; Alejo M; Leon X; Quer M; Bagué S; Mesia R; Nogués J; Gomà M; Aguila A; Bonfill T; Blazquez C; Guix M; Hijano R; Torres M; Holzinger D; Pawlita M; Pavon MA; Bravo IG; de Sanjosé S; Bosch FX; Alemany L
Oral Oncol; 2018 Mar; 78():137-144. PubMed ID: 29496041
[TBL] [Abstract][Full Text] [Related]
13. 2011-2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France.
Gorphe P; Blanchard P; Garcia GCTE; Classe M; Even C; Temam S; Breuskin I
BMC Cancer; 2022 Sep; 22(1):1000. PubMed ID: 36127667
[TBL] [Abstract][Full Text] [Related]
14. Increasing HPV vaccination coverage to prevent oropharyngeal cancer: A cost-effectiveness analysis.
Choi SE; Choudhary A; Huang J; Sonis S; Giuliano AR; Villa A
Tumour Virus Res; 2022 Jun; 13():200234. PubMed ID: 34974194
[TBL] [Abstract][Full Text] [Related]
15. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
[TBL] [Abstract][Full Text] [Related]
16. Increasing prevalence of HPV in oropharyngeal carcinoma suggests adaptation of p16 screening in Southeast Asia.
Argirion I; Zarins KR; McHugh J; Cantley RL; Teeramatwanich W; Laohasiriwong S; Kasemsiri P; Naruikon J; Srimanta P; Chinn SB; Vatanasapt P; Rozek LS
J Clin Virol; 2020 Nov; 132():104637. PubMed ID: 32932151
[TBL] [Abstract][Full Text] [Related]
17. Incidence, trends, and survival of oropharyngeal squamous cell cancer in Aotearoa New Zealand, 2006-2020.
Win Myint TT; McIvor N; Douglas R; Tin Tin S; Elwood M
Cancer Epidemiol; 2023 Aug; 85():102393. PubMed ID: 37267678
[TBL] [Abstract][Full Text] [Related]
18. Impact of smoking on stage-specific survival in human papilloma virus-associated oropharyngeal squamous cell carcinoma.
Horwich P; Gundale A; Patin S; Flores J; Moore Medlin T; Chang BA; Nathan CO
Head Neck; 2021 Sep; 43(9):2698-2704. PubMed ID: 34002904
[TBL] [Abstract][Full Text] [Related]
19. Is 2045 the best we can do? Mitigating the HPV-related oropharyngeal cancer epidemic.
Schuman A; Anderson KS; Day AT; Ferrell J; Sturgis EM; Dahlstrom KR
Expert Rev Anticancer Ther; 2022 Jul; 22(7):751-761. PubMed ID: 35679626
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma.
Weiss BG; Anczykowski MZ; Küffer S; Spiegel JL; Bertlich M; Canis M; Ihler F; Kitz J; Jakob M
Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1983-2000. PubMed ID: 32814982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
